HALO logo
halo search icon
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc.
RARE · NAS

Ultragenyx Pharmaceutical, Inc.

US$23.37

Price Arrow0.92 (4.10%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Ultragenyx Pharmaceutical, Inc. Overview

RARE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Strong

About RARE

icon

Telephone

1.415.483.8800

icon

Address

60 Leveroni Court, Novato, CA 94949

Description

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

RARE Price Chart

Key Stats

Market Cap

US$2.21B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 18.29 - 42.37

Trade Value (12mth)

US$13,571,211.00

1 week

-10.2%

1 month

-6.85%

YTD

-4.87%

1 year

-36.6%

All time high

179.65

Key Fundamentals

EPS 3 yr Growth

-42.40%

EBITDA Margin

-74.30%

Operating Cashflow

-$466m

Free Cash Flow Return

-42.40%

ROIC

-52.40%

Interest Coverage

-8.10

Quick Ratio

2.30

Other Data

Shares Outstanding (Fully Diluted)

101m

HALO Sector

Healthcare

Next Company Report Date

18-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

RARE Announcements

Latest Announcements

DateAnnouncements
19 May 26
19 May 26
06 May 26
06 May 26
06 May 26

RARE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-8.25-6.29-5.83locklocklock
EPS (Fully Diluted)
$locklocklocklock-8.25-6.29-5.83locklocklock
Growth
%locklocklocklock18.523.87.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Ultragenyx Pharmaceutical, Inc. (RARE:NAS)?
Halo FAQ
The current share price of Ultragenyx Pharmaceutical, Inc. (RARE:NAS) is USD$23.37.
What is the 52-week high share price for Ultragenyx Pharmaceutical, Inc. (RARE:NAS)?
Halo FAQ
The 52-week high share price for Ultragenyx Pharmaceutical, Inc. (RARE:NAS) is USD$42.37.
What is the 52-week low share price for Ultragenyx Pharmaceutical, Inc. (RARE:NAS)?
Halo FAQ
The 52-week low share price for Ultragenyx Pharmaceutical, Inc. (RARE:NAS) is USD$18.29.
What is the dividend yield for Ultragenyx Pharmaceutical, Inc. (RARE:NAS)?
Halo FAQ
Ultragenyx Pharmaceutical, Inc. (RARE:NAS) does not pay a dividend.
What was Ultragenyx Pharmaceutical, Inc. (RARE:NAS) last dividend payment?
Halo FAQ
Ultragenyx Pharmaceutical, Inc. (RARE:NAS) does not pay a dividend.
What is the franking level for Ultragenyx Pharmaceutical, Inc. (RARE:NAS)?
Halo FAQ
Ultragenyx Pharmaceutical, Inc. (RARE:NAS) has a franking level of 0.00%.
In which sector is Ultragenyx Pharmaceutical, Inc. (RARE:NAS) classified?
Halo FAQ
Ultragenyx Pharmaceutical, Inc. (RARE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.